Skip to main content

Clinical Trials › NCT05767736

Active, Not Recruiting

A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)

Sponsored by Biogen

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
10500
Target enrollment
1
U.S. states
Jun 2024
Start date
Dec 2032
Expected completion

Interventions / Treatments

Diroximel FumarateDimethyl FumarateDisease-Modifying Therapies (DMTs)

Conditions studied

Multiple Sclerosis

Where this trial is running (1 site)

Cambridge

MS centers in Massachusetts

Compare treatment centers near a trial site by center type, providers and trials.

View Massachusetts centers
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play